Evidence map›Paper›PMID 27411387›Full record

ArticleBMC cancer2016

5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells.

Seok-Woo Park, J Hun Hah, Sang-Mi Oh, Woo-Jin Jeong, Myung-Whun Sung

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of Cannabinoids in Oral Cancer.International journal of molecular sciences · 2024
    Review
  4. Inflammation and cancer: friend or foe?Frontiers in pharmacology · 2024
    Review
  5. Review
  6. Article
  7. PUFA-DerivedACS chemical biology · 2022
    Article
  8. Review
  9. Biomolecules · 2019
    Review
  10. Novel COX-2 products ofJournal of lipid research · 2019
    Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Seok-Woo ParkCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
J Hun HahCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Sang-Mi OhCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Woo-Jin JeongDepartment of Otorhinolaryngology, Seoul National University Bundang Hospital, Seoul, South Korea.
Myung-Whun SungCancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. mwsung@snu.ac.kr.
Seoul National University · KRSeoul National University Bundang Hospital · KRSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndocannabinoids have recently drawn attention as promising anti-cancer agents. We previously observed that anandamide (AEA), one of the representative endocannabinoids, effectively inhibited the proliferation of head and neck squamous cell carcinoma (HNSCC) cell lines in a receptor-independent manner. In this study, using HNSCC cell lines, we examined the anti-cancer effects and the mechanisms of action of docosahexaenoyl ethanolamide (DHEA) and N-arachidonoyl-L-alanine (NALA), which are polyunsaturated fatty acid (PUFA)-based ethanolamides like AEA. METHODS AND

resultsDHEA and NALA were found to effectively inhibit HNSCC cell proliferation. These anti-proliferative effects seemed to be mediated in a cannabinoid receptor-independent manner, since the antagonist of cannabinoid receptor-1 (CB1) and vanilloid receptor-1 (VR1), two endocannabinoid receptors, did not reverse the ability of DHEA and NALA to induce cell death. Instead, we observed an increase in reactive oxygen species (ROS) production and a decrease of phosphorylated Akt as a result of DHEA and NALA treatment. Antioxidants efficiently reversed the inhibition of cell proliferation and the decrease of phosphorylated Akt induced by DHEA and NALA; inhibition of 5-lipoxygenase (5-LO), which is expected to be involved in DHEA- and NALA-degradation pathway, also partially blocked the ability of DHEA and NALA to inhibit cell proliferation and phosphorylated Akt. Interestingly, ROS production as a result of DHEA and NALA treatment was decreased by inhibition of 5-LO.

conclusionsFrom these findings, we suggest that ROS production induced by the 5-LO pathway mediates the anti-cancer effects of DHEA and NALA on HNSCC cells. Finally, our findings suggest the possibility of a new cancer-specific therapeutic strategy, which utilizes 5-LO activity rather than inhibiting it.

Indexed as

AlanineAntineoplastic AgentsApoptosisArachidonate 5-LipoxygenaseArachidonic AcidsAzolesBenzoquinonesCarcinogenesisCarcinoma, Squamous CellCell Line, TumorCell ProliferationEndocannabinoidsHead and Neck NeoplasmsHumansHydroxyureaIsoindoles2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinoneAlanineALOX5 protein, humanAM 251Antineoplastic AgentsArachidonate 5-LipoxygenaseArachidonic AcidsAzolesBenzoquinonesCNR1 protein, humanebselenEndocannabinoidsHydroxyureaIsoindolesLipoxygenase InhibitorsN-arachidonoylalanineN-docosahexaenoylethanolamideOrganoselenium CompoundsPiperidinesProto-Oncogene Proteins c-aktPyrazolesReactive Oxygen SpeciesReceptor, Cannabinoid, CB1TRPV1 protein, humanTRPV Cation Channelszileuton5-lipoxygenaseDHEAEndocannabinoidHead and neck cancerNALAROS

Identifiers

PMID27411387
PMCPMC4942960
OpenAlexW2469023840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.